MARY YOUNGER: Open Payments
NPI 1295513364 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 33 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $845 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $323 |
| HARMONY BIOSCIENCES LLC | 4 | $140 |
| Alpha Cognition USA, Inc. | 1 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| Viatris Specialty LLC | 3 | $81 |
| Verona Pharma, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Eisai Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $15 |
Products named: FARXIGA, WAKIX, AIRSUPRA, Zunveyl, Kerendia, YUPELRI, Ohtuvayre, TRELEGY ELLIPTA.
Industry payments across NM — which companies pay providers there.
